Similar Stories to Biotech Stocks: Analyst Downgrades Weigh On Drug Stocks on Bing News

Shares of Regeneron, Curis and Endo Pharmaceuticals are falling in early trading following analyst downgrades.

BING NEWS:
  • This Texas Instruments Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Today
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Trending: ...
    05/13/2024 - 2:06 am | View Link
  • Analyst unveils Amgen stock price target after weight-loss drug update
    The Thousand Oaks, Calif.-based company reported first-quarter results on Thursday, including an update on its weight loss drug in development, which led analysts to update their Amgen stock price ...
    05/3/2024 - 11:53 am | View Link
  • Amgen jumps after teasing weight-loss drug data, rival stocks fall
    Amgen shares headed for their best session since 2009 on Friday after the U.S. drugmaker hinted at encouraging interim trial data on its experimental obesity drug, denting rival stocks but leaving ...
    05/3/2024 - 2:42 am | View Link
  • Analyst Upgrades: 3 Stocks That the Pros Can’t Stop Raving About
    InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sell-side analysts have ratings on specific stocks, and based on them, they ...
    05/1/2024 - 7:37 am | View Link
  • 3 'Buy-Rated' Biotech Stocks Under $10
    In this column, I highlight three biotech stocks with favorable risk/reward ... FY2023 on just under $260 million in sales. The current analyst firm consensus has the company churning out a ...
    04/27/2024 - 10:39 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News